Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome
Trial Parameters
Brief Summary
This randomized clinical trial investigates the effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study involves 28 male and female children aged 2-10 years old, who will be randomly assigned to one of the two groups i.e. control and experimental group. Key performance outcomes -GMFM 88 and gait outcome assessment -will be assessed both before and after the intervention. The research aims to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e. its spacial parameters that are step length, stride length, stride width, In and out toe and BOS and functional mobility Data will be analyzed through SPSS version 27.00.
Eligibility Criteria
Inclusion Criteria: * Age: 2-10 years old * Confirmed diagnosis of Down syndrome by pediatric neurologist. * Written informed consent obtained from parents or guardians. * Independent standing and walking abilities assessed by GMFM dimension D and E. * Functional hearing and vision, and understanding of instructions which were necessary for the measurement procedures * No other physical therapy or interventions within the past three months Exclusion Criteria: * Presence of other significant medical conditions (e.g., severe cardiac issues). * History of orthopedic surgery or significant musculoskeletal issues affecting mobility. * Any additional neurological disorders that could confound results. * Patient with Serious cognitive \& behavior issues that would interfere with group participation. * Participation in other clinical trials during the study period